Fresenius Medical Care AG & Co. KGaA

$ 39.37 -0.7 (-1.75%)
Volume: 338,955 Avg Vol (1m): 206,141
Market Cap $: 24.16 Bil Enterprise Value $: 31.45 Bil
P/E (TTM): 10.88 P/B: 1.84
Earnings Power Value 18.3
Net Current Asset Value -12.1
Tangible Book -2.07
Projected FCF 40.85
Median P/S Value 44.73
Graham Number 0
Peter Lynch Value 43.69
DCF (FCF Based) 30.44
DCF (Earnings Based) 52.7
YTD (-%)

Financial Strength : 6/10

Current vs industry vs history
Cash-to-Debt 0.30
Equity-to-Asset 0.45
Debt-to-Equity 0.64
Debt-to-EBITDA 1.93
Interest Coverage 4.78
Piotroski F-Score 7
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.54
DISTRESS
GREY
SAFE
Beneish M-Score -2.57
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 10.63%
WACC 6.84%

Profitability & Growth : 9/10

Current vs industry vs history
Operating Margin % 12.95
Net Margin % 11.98
ROE % 18.15
ROA % 7.93
ROC (Joel Greenblatt) % 69.79
3-Year Total Revenue Growth Rate 2.60
3-Year Total EBITDA Growth Rate 10.60
3-Year EPS w/o NRI Growth Rate 27.30

» FMS's 30-Y Financials

Financials (Next Earnings Date: 2019-05-02)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NYSE:FMS

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Health Care Providers » Medical Care    NAICS : 621492    SIC : 8092
Compare NYSE:HCA XTER:FRE XKLS:5225 SZSE:300015 NYSE:DVA BKK:BDMS NYSE:UHS LSE:NMC ASX:RHC ASX:SHL LSE:MDC NYSE:EHC NYSE:CHE NYSE:EVHC BKK:BH NYSE:MD JSE:LHC JSE:NTC NAS:ACHC NYSE:AMN
Traded in other countries FME.Austria FMEN.Germany FME.Italy FMEN.Mexico FME.Switzerland 0H9X.UK
Address Else-Kroener-Strasse 1, Bad Homburg, DEU, 61352
Based in Germany, Fresenius Medical Care is the largest global dialysis provider, with over 300,000 patients in North America, Europe, Latin America, and Asia. Fresenius operates over 2,270 clinics in North America, 700 in Europe, 360 in Asia-Pacific, and 230 in Latin America. Fresenius also sells dialysis machines and disposables, which represent nearly 20% of the company's revenue.

Ratios

Current vs industry vs history
PE Ratio (TTM) 10.88
Forward PE Ratio 15.82
N/A
PE Ratio without NRI 10.88
Price-to-Owner-Earnings 8.78
PB Ratio 1.84
PS Ratio 1.30
Price-to-Free-Cash-Flow 21.45
Price-to-Operating-Cash-Flow 10.45
EV-to-EBIT 8.78
EV-to-EBITDA 7.15
EV-to-Revenue 1.69
PEG Ratio 0.96
Shiller PE Ratio 19.99
Current Ratio 1.25
Quick Ratio 1.02
Days Inventory 35.92
Days Sales Outstanding 73.62
Days Payable 20.55

Dividend & Buy Back

Current vs industry vs history
Dividend Yield % 1.61
Dividend Payout Ratio 0.17
3-Year Dividend Growth Rate (Per Share) 10.80
Forward Dividend Yield % 1.61
N/A
Yield-on-Cost (5-Year) % 2.28
3-Year Share Buyback Rate -0.20

Valuation & Return

Current vs industry vs history
Price-to-Projected-FCF 0.97
Price-to-DCF (Earnings Based) 0.75
Price-to-Median-PS-Value 0.88
Price-to-Peter-Lynch-Fair-Value 0.90
Earnings Yield (Joel Greenblatt) % 11.39
Forward Rate of Return (Yacktman) % 16.53

More Statistics

Revenue (TTM) (Mil) $ 19,451.66
EPS (TTM) $ 3.78
Beta 1.94
Volatility % 37.15
52-Week Range $ 30.99 - 53.4
Shares Outstanding (Mil) 613.76

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 7
Positive ROA Y
Positive CFROA Y
Higher ROA yoy Y
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy Y
Less Shares Outstanding yoy Y
Higher Gross Margin yoy N
Higher Asset Turnover yoy N